Antibiotic policies in European hospitals

Medecine et Maladies Infectieuses

Volumn 35, Issue SUPPL. 2, 2005, Pages

  Gould, I M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antibiotics; Hospital; Policy

Indexed keywords

COTRIMOXAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; CROSS INFECTION; DISEASE EXACERBATION; DRUG INDUSTRY; DRUG MONITORING; EDUCATION PROGRAM; GEOGRAPHICAL VARIATION (SPECIES); GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEALTH CARE POLICY; MEDICAL AUDIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRESCRIPTION; SHORT SURVEY;

EID: 20744439512     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(05)81298-3     Document Type: Article

References (7)

1. Goossens H, Ferech M, Vander Stichele R, Elseviers M ESAC Project Group Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 587
2. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, and Oh MD Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on outcome Clin Infect Dis 37 2003 745 751
3. Gould IM Antibiotic policies and control of resistance Curr Opin Infect Dis 15 2002 385 400
4. Knox K, Lawson W, and Holmes A Multidisciplinary antimicrobial management teams and the role of the pharmacist in management of infection Gould IM van der Meer JWM Antibiotic Policies: Theory and Practice 2005 Kluwer Academic/Plenum Publishers 227 249
5. Gould IM, Clarke R, Hutchinson S, and Davey P Variation in European antibiotic use Lancet 358 2001 1273
6. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F., and Hooper DC Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China Antimicrob Agents Chemother 47 2003 2242 2248
7. Gould IM Pharmacodynamics and the relationship between in vitro and in vivo of antimicrobial agents J Chemother 9 1997 74 83